Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Harms

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Journal of Digital Imaging|May 17, 2007
Effect of automated image registration on radiologist interpretationBradley J Erickson, Jayawant Mandrekar, Liqin Wang, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Optics Letters|June 16, 2018
Hartmann wavefront sensor characterization of a high charge vortex beam in the extreme ultraviolet spectral rangeF Sanson, A K Pandey, F Harms, et al.
Cancer Research|August 17, 2005
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasisJennifer E Koblinski, Benjamin R Kaplan-Singer, Sherilyn J VanOsdol, et al.
Optics Letters|September 2, 2020
Highly multimodal structure of high topological charge extreme ultraviolet vortex beamsF Sanson, A K Pandey, I Papagiannouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Clinical & Experimental Metastasis|February 6, 2002
Analysis of mechanisms underlying BRMS1 suppression of metastasisR S Samant, M J Seraj, M M Saunders, et al.
Translational Psychiatry|September 28, 2016
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9AM S Alexander, M J Gasperini, P T Tsai, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|October 7, 2010
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's diseaseRobin J Kleiman, Lida H Kimmel, Susan E Bove, et al.
Journal of Digital Imaging|May 17, 2007
Effect of automated image registration on radiologist interpretationBradley J Erickson, Jayawant Mandrekar, Liqin Wang, et al.
Pancreas|May 26, 2009
Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expressionGail L Matters, John F Harms, Christopher O McGovern, et al.
Optics Letters|June 16, 2018
Hartmann wavefront sensor characterization of a high charge vortex beam in the extreme ultraviolet spectral rangeF Sanson, A K Pandey, F Harms, et al.
Cancer Research|August 17, 2005
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasisJennifer E Koblinski, Benjamin R Kaplan-Singer, Sherilyn J VanOsdol, et al.
Optics Letters|September 2, 2020
Highly multimodal structure of high topological charge extreme ultraviolet vortex beamsF Sanson, A K Pandey, I Papagiannouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Kinetics of metastatic breast cancer cell trafficking in bonePushkar A Phadke, Robyn R Mercer, John F Harms, et al.
Journal of Medicinal Chemistry|July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophreniaPatrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Clinical & Experimental Metastasis|February 6, 2002
Analysis of mechanisms underlying BRMS1 suppression of metastasisR S Samant, M J Seraj, M M Saunders, et al.
Translational Psychiatry|September 28, 2016
Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9AM S Alexander, M J Gasperini, P T Tsai, et al.
Pageof 6